Antioxidants successfully reduce ROS production in propionic acidemia fibroblasts

作者：Gallego Villar Lorena; Perez Belen; Ugarte Magdalena; Desviat Lourdes R; Richard Eva^*

来源：Biochemical and Biophysical Research Communications, 2014, 452(3): 457-461.

DOI：10.1016/j.bbrc.2014.08.091

• Propionic acidemia
• Antioxidants
• Resveratrol
• MitoQ
• Tiron
• Trolox

Propionic acidemia (PA), caused by a deficiency of the mitochondrial biotin dependent enzyme propionyl-CoA carboxylase (PCC) is one of the most frequent organic acidurias in humans. Most PA patients present in the neonatal period with metabolic acidosis and hyperammonemia, developing different neurological symptoms, movement disorders and cardiac complications. There is strong evidence indicating that oxidative damage could be a pathogenic factor in neurodegenerative, mitochondrial and metabolic diseases. Recently, we identified an increase in ROS levels in PA patients-derived fibroblasts. Here, we analyze the capability of seven antioxidants to scavenge ROS production in PA patients' cells. Tiron, trolox, resveratrol and MitoQ significantly reduced ROS content in patients and controls' fibroblasts. In addition, changes in the expression of two antioxidant enzymes, superoxide dismutase and glutathione peroxidase, were observed in PA patients-derived fibroblasts after tiron and resveratrol treatment. Our results in PA cellular models establish the proof of concept of the potential of antioxidants as an adjuvant therapy for PA and pave the way for future assessment of antioxidant strategies in the murine model of PA.

• 出版日期2014-9-26